Rosetta Inpharmatics Overview
- Founded
-
1996
- Status
-
Acquired/Merged
- Employees
-
175
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
Rosetta Inpharmatics General Information
Description
Provider of an informational genomics platform. The company's integrated platform includes the design and analysis of proprietary DNA microarrays, a powerful, flexible informatics system and advanced molecular biology techniques to support gene expression profiling programs.
Contact Information
Website
www.rii.com
Formerly Known As
Rosetta Biosystems
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Other Healthcare Technology Systems
Acquirer
Primary Office
- 12040-115th Avenue
- North East
- Kirkland, WA 98034
- United States
Rosetta Inpharmatics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Rosetta Inpharmatics Executive Team (6)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Jasper Rine | Co-Founder | ||
| Stephen Friend | Co-Founder | ||
| Leroy Hood Ph.D | Co-Founder |
Rosetta Inpharmatics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Rosetta Inpharmatics Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|